Supporting adherence to the cystic fibrosis regimen: Development and validation of The Daily Care Check-In (DCC).

IF 5.4 2区 医学 Q1 RESPIRATORY SYSTEM Journal of Cystic Fibrosis Pub Date : 2024-10-31 DOI:10.1016/j.jcf.2024.10.011
Kristin A Riekert, Christine Ford, Andrea Goodman, Thomas Eckmann, Angela Green, Alexandra L Quittner
{"title":"Supporting adherence to the cystic fibrosis regimen: Development and validation of The Daily Care Check-In (DCC).","authors":"Kristin A Riekert, Christine Ford, Andrea Goodman, Thomas Eckmann, Angela Green, Alexandra L Quittner","doi":"10.1016/j.jcf.2024.10.011","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The cystic fibrosis (CF) regimen is time-consuming and burdensome leading to barriers to self-management. This mixed-methods study developed the Daily Care Check-in (DCC) that is specific to the barriers faced by people with CF (PWCF) and evaluated its validity.</p><p><strong>Methods: </strong>Qualitative methods were used to identify barriers to self-management and develop items, with \"think aloud\" cognitive interviews conducted to refine the items. A multisite, cross-sectional study was conducted to test the internal consistency, test-retest reliability, and validity of the DCC scores, comparing them to objective medication adherence (composite medication possession ratio (cMPR)) and psychosocial measures (self-efficacy, medication beliefs, executive functioning, depressive and anxiety symptoms, treatment burden, and treatment complexity).</p><p><strong>Results: </strong>The DCC (18 items) includes two scales: Occurrence (score range 0-18) and Interference (score range 0-90). 405 participants completed the DCC, 344 (85 %) completed the survey, and 365 (90 %) had a cMPR calculated. On average, 6.8 barriers were reported (SD = 4.2 Occurrence Scale), and the Interference Scale had a mean score of 18.4 (SD = 14.0). Reliability was acceptable to good. cMPR was negatively correlated with the DCC (rho=-0.26, Occurrence and rho = -0.31, Interference, p-values<0.0001). A priori hypotheses between the DCC and the other measures were supported and demonstrated construct validity.</p><p><strong>Conclusions: </strong>This study provides evidence supporting the validity of the DCC for assessing the presence and impact of barriers to CF self-management, including medication adherence. Formal screening of self-management barriers (e.g., using the DCC) should be considered to facilitate conversations with the care team and identify tailored interventions to support CF self-management.</p>","PeriodicalId":15452,"journal":{"name":"Journal of Cystic Fibrosis","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cystic Fibrosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jcf.2024.10.011","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The cystic fibrosis (CF) regimen is time-consuming and burdensome leading to barriers to self-management. This mixed-methods study developed the Daily Care Check-in (DCC) that is specific to the barriers faced by people with CF (PWCF) and evaluated its validity.

Methods: Qualitative methods were used to identify barriers to self-management and develop items, with "think aloud" cognitive interviews conducted to refine the items. A multisite, cross-sectional study was conducted to test the internal consistency, test-retest reliability, and validity of the DCC scores, comparing them to objective medication adherence (composite medication possession ratio (cMPR)) and psychosocial measures (self-efficacy, medication beliefs, executive functioning, depressive and anxiety symptoms, treatment burden, and treatment complexity).

Results: The DCC (18 items) includes two scales: Occurrence (score range 0-18) and Interference (score range 0-90). 405 participants completed the DCC, 344 (85 %) completed the survey, and 365 (90 %) had a cMPR calculated. On average, 6.8 barriers were reported (SD = 4.2 Occurrence Scale), and the Interference Scale had a mean score of 18.4 (SD = 14.0). Reliability was acceptable to good. cMPR was negatively correlated with the DCC (rho=-0.26, Occurrence and rho = -0.31, Interference, p-values<0.0001). A priori hypotheses between the DCC and the other measures were supported and demonstrated construct validity.

Conclusions: This study provides evidence supporting the validity of the DCC for assessing the presence and impact of barriers to CF self-management, including medication adherence. Formal screening of self-management barriers (e.g., using the DCC) should be considered to facilitate conversations with the care team and identify tailored interventions to support CF self-management.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
支持坚持囊性纤维化治疗方案:日常护理签到 (DCC) 的开发与验证。
背景:囊性纤维化(CF)疗程耗时且负担沉重,导致患者在自我管理方面遇到障碍。这项混合方法研究针对囊性纤维化患者(PWCF)面临的障碍开发了日常护理签到(DCC),并对其有效性进行了评估:方法:采用定性方法确定自我管理的障碍并开发项目,同时进行 "大声思考 "认知访谈以完善项目。我们进行了一项多地点横断面研究,以检验 DCC 分数的内部一致性、测试-再测试可靠性和有效性,并将其与客观用药依从性(复合药物持有率 (cMPR))和社会心理测量(自我效能、用药信念、执行功能、抑郁和焦虑症状、治疗负担和治疗复杂性)进行比较:DCC(18 个项目)包括两个量表:结果:DCC(18 个项目)包括两个量表:发生(分值范围 0-18)和干扰(分值范围 0-90)。405 名参与者完成了 DCC,344 人(85%)完成了调查,365 人(90%)计算了 cMPR。报告的障碍平均为 6.8 个(SD = 4.2 个发生量表),干扰量表的平均分为 18.4 分(SD = 14.0 分)。cMPR 与 DCC 呈负相关(rho=-0.26,发生量表;rho=-0.31,干扰量表,p 值):本研究提供的证据支持了 DCC 在评估 CF 自我管理障碍(包括服药依从性)的存在和影响方面的有效性。应考虑对自我管理障碍进行正式筛查(如使用 DCC),以促进与护理团队的对话,并确定支持 CF 自我管理的定制干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cystic Fibrosis
Journal of Cystic Fibrosis 医学-呼吸系统
CiteScore
10.10
自引率
13.50%
发文量
1361
审稿时长
50 days
期刊介绍: The Journal of Cystic Fibrosis is the official journal of the European Cystic Fibrosis Society. The journal is devoted to promoting the research and treatment of cystic fibrosis. To this end the journal publishes original scientific articles, editorials, case reports, short communications and other information relevant to cystic fibrosis. The journal also publishes news and articles concerning the activities and policies of the ECFS as well as those of other societies related the ECFS.
期刊最新文献
Vitality is associated with systemic inflammation in cystic fibrosis adults on elexacaftor/tezacaftor/ivacaftor. Adverse events to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis due to elevated drug exposure?: A case series. Application of the defect distribution index to functional lung MRI of pediatric cystic fibrosis lung disease and controls. CFTR modulators and pregnancy outcomes: Early findings from a nationwide cohort study. Anti-inflammatory activity of Pseudomonas aeruginosa DEV phage in cystic fibrosis models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1